CELEX: C2005/182/20
Language: en
Date: 2005-07-23 00:00:00
Title: Judgment of the Court (Second Chamber) of 12 May 2005 in Case C-444/03: Reference for a preliminary ruling from the Verwaltungsgericht Berlin Meta Fackler KG v Bundesrepublik Deutschland (Medicinal products for human use — Homeopathic medicinal products — National provision excluding from the special, simplified registration procedure a medicinal product composed of known homeopathic substances if its use as a homeopathic medicinal product is not generally known)

23.7.2005   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 182/11
            
         
      JUDGMENT OF THE COURT
   
   (Second Chamber)
   of 12 May 2005
   in Case C-444/03: Reference for a preliminary ruling from the Verwaltungsgericht Berlin Meta Fackler KG v Bundesrepublik Deutschland (1)
   
   (Medicinal products for human use - Homeopathic medicinal products - National provision excluding from the special, simplified registration procedure a medicinal product composed of known homeopathic substances if its use as a homeopathic medicinal product is not generally known)
   (2005/C 182/20)
   Language of the case: German
   In Case C-444/03: reference for a preliminary ruling under Article 234 EC from the Verwaltungsgericht Berlin (Germany), made by decision of 28 August 2003, received at the Court on 21 October 2003, in the proceedings between Meta Fackler KG and Bundesrepublik Deutschland — the Court (Second Chamber), composed of C.W.A. Timmermans, President of the Chamber, R. Silva de Lapuerta, C. Gulmann (Rapporteur), P. Kūris and J. Klučka, Judges; P. Léger, Advocate General, K. Sztranc, Administrator, for the Registrar, gave a judgment on 12 May 2005, the operative part of which is as follows:
   Articles 14 and 15 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use must be interpreted as meaning that they preclude a national provision which does not permit use of the special simplified registration procedure for a medicinal product composed of several known homeopathic substances where its use as a homeopathic medicinal product is not generally known.
   
      (1)  OJ C 21 of 24.01.2004.